Greater Mortality Risk With Antipsychotics in Parkinson's

But risk appears lower with atypical antipsychotics.

SAN DIEGO -- Parkinson's patients taking antipsychotics have a greater risk of death than those not on the drugs, researchers reported here.

In a retrospective analysis of Veterans Affairs data, those taking antipsychotics were twice as likely to die in the 180 days after starting therapy compared with those not on the drugs (HR 2.35, 95% CI 2.08 to 2.66, P<0.001), according to Daniel Weintraub, MD, of the University of Pennsylvania, and colleagues.

They reported their findings during a poster session at the Movement Disorders Society meeting here.

About 60% of Parkinson's patients experience psychosis over the course of the disease, and about half of those who are actually diagnosed with psychosis receive treatment.

Studies in the general population have shown that use of antipsychotics is associated with increased mortality. To determine whether that is also the case for patients with Parkinson's, Weintraub...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.medpagetoday.com/MeetingCoverage/MDS/52209